Of USD 200 million capex, USD 100 million will go into four key areas- Syngene Research Centre, biologic centre, formulation center, viral testing and the rest in commercial manufacturing, says Jonathan Hunt, CEO of Syngene International.
first published: Jul 22, 2016 01:13 pm
A collection of the most-viewed Moneycontrol videos.
Nifty recovers from day’s low to edge back above 26,000 | Closing Bell Live
Tax Saving Tips: How sections 54 & 54F can reduce tax to zero
Can Nifty Extend Its Upmove After Back-To Back Gains? Insurance Stocks In Focus| Opening Bell Live
From Mini-Mumbai to the Real Mumbai: What Brought This Tenant to Andheri | The Tenant
